ClinicalTrials.gg
RecruitingNCT07638839VEGETARIANSUpdated Jun 10, 2026

Dietary Quality and Nutritional Adequacy Among Vegetarians Attending the European Institute of Oncology

An interventional study of personalized nutritional counseling in Nutritional Deficiencies and Quality of Life, sponsored by European Institute of Oncology. Recruiting at 1 site in Italy. Open to female participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by European Institute of Oncology · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
18 Years to 64 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Malnutrition with a site in Italy — 9 open to participants now, 11 under way, none of them phase 3. Malnutrition · Italy.

Planned enrollment
7th of 20
150 · median 119
Started
2026
with 2 others
No phase
17 of 44
7 open now
Primary completion
2028-01
later than 9 of 10 live
Registered
40th of 44
by date

Among the 44 studies in Malnutrition with a site in Italy, this one is the 7th largest by planned enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2026, is one of 17 with no phase, reaches primary completion later than 9 of the 10 other live ones, and was the 40th registered.

Malnutrition

1,278 studies on the registry are indexed under Malnutrition; 231 are open to participants now.

Browse Malnutrition studies →

Open to participants now

9 of the 44 studies in Malnutrition with a site in Italy are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 150 Malnutrition studies recruiting now, 84 (56%) set no upper age limit and 44 (29%) stop at 75 or younger; 40 take children under 18; 30 take healthy volunteers.

This study: 18 Years to 64 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Malnutrition with a site in Italy, or all of them as a file.
02

Study summary

Despite their health benefits, vegetarian dietary patterns can lead to malnutrition and micronutrient deficiencies if improperly managed, especially in oncological settings. This survey assesses dietary quality and adequacy in 150 women (18-64 years), further examining how a threemonth nutritional counseling intervention influences body composition, physical activity, and quality of life.

Read the detailed description

150 vegan, vegetarian, semi-vegetarian women (18-64 years) will be recruited among patients attending the European Institute of Oncology for prevention visits or oncological follow-up. The study will include a baseline visit and a 3-month follow-up visit, with an interim telephone contact.

At baseline, nutritional adequacy and diet quality will be assessed, followed by a personalized nutritional counselling aimed at improving dietary variety, ensuring adequate nutrient intake, and promoting an active lifestyle. The intervention will be based on a vegetarian adaptation of the Healthy Eating Plate and aligned with national and international guidelines (CREA,2019; WCRF, 2018).

During study visits, anthropometric measurements (height, weight, waist and hip circumferences), body composition (BIVA), and blood samples will be collected. Dietary intake will be evaluated via a 3-day food records. Validated questionnaires will be administered to assess physical activity (IPAQ-SF), adherence to the Mediterranean diet (QueMD), and quality of life (VEGQOL). Additionally, vegetarian diet quality and lifestyle will be evaluated using the Vegetarian Lifestyle Index.

Nutritional adequacy will be determined by comparing dietary intake and blood biomarkers with Italian Dietary Reference Values (DRVs; SINU 2024).

03

Conditions studied

  • Nutritional Deficiencies
  • Quality of Life

Browse trials for

Keywords

  • vegan
  • vegetarian
  • semivegetarian diet
04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pre or women, aged between 18 and 64;
  • healthy participants or high-risk cancer patients or patients with previous diagnosis of neoplasia
  • self-identifying as vegan (defined as excluding all animal products), or vegetarian (defined as excluding all animal products besides eggs and/or dairy) or semi-vegetarian (defined as excluding no animal products but limiting meat to \< 1× per week);
  • ability to understand and the willingness to sign a written document;

Exclusion criteria

Exclusion Criteria:

  • any condition which, in the opinion of the investigator, may impede testing of the study hypothesis or make it unsafe to engage in the study (e.g., ulcerative colitis, Crohn's disease etc.);
  • any diagnosis of invasive neoplasia, within the previous 1 years, except non-melanoma skin cancer;
  • currently receiving chemotherapy, radiation, or immunotherapy as cancer treatment;
  • patients dependent on enteral or parental nutrition;
  • pregnancy or lactation;
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    vegetarian study population

    The study population comprises 150 women (18-64 years) adhering to plant-based diets (vegan, vegetarian, or semi-vegetarian), including both healthy individuals and those with a history or high risk of cancer recruited at the European Institute of Oncology (Milan, IT)

    Other: personalized nutritional counseling

Interventions

  • Otherpersonalized nutritional counseling

    Participants will receive personalized nutritional counseling by registered dietitians based on blood tests and 3-day food records, focusing on improving diet variety and optimizing intake of critical nutrients. Additionally, lifestyle advice will be provided to increase physical activity and reduce sedentary behavior.

06

What researchers measure

Primary outcomes

  1. Survey on nutritional adequacy of participants' diet at baseline

    Nutritional adequacy evaluated through blood biomarkers and dietary intake, assessed via 3-day food records. Nutrient data will be referenced against the Italian Dietary Reference Values (DRVs). Nutritional adequacy will be quantified by calculating the Nutrient Adequacy Ratio (NAR) and the Mean Adequacy Ratio (MAR). The NAR represents the ratio of an individual's nutrient intake to the corresponding Italian DRV for their age group, while the MAR is the average of all calculated NARs. Both indices will be expressed on a scale from 0 to 1, where 0 indicates that nutrient requirements are not met and 1 indicates that they are fully met.

    Time frame: Baseline

  2. Survey on dietary and lifestyle quality of participants at baseline

    A modified version of the vegetarian Lifestyle index is adapted to Italian guidelines and national recommendations. The score comprises 11 dietary and 3 lifestyle components and ranges from 0 to 14, with higher score indicating greater adherence.

    Time frame: Baseline

Secondary outcomes

  1. Nutrient Adequacy Ratio (NAR)

    change in NAR calculated by dividing participant's intake of a given nutrient by the Italian DRVs for the corresponding age category

    Time frame: 3-month

  2. Mean Adequacy Ratio (MAR)

    change in MAR calculated by averaging all NARs together

    Time frame: 3-month

  3. Vegetarian life style index (VLI)

    change in vegetarian Lifestyle score ranging from 0 to 14, with higher score indicating greater adherence.

    Time frame: 3-month

  4. Blood analysis- glucose

    change in concentration of glucose (mg/dl)

    Time frame: 3-month

  5. Blood analysis- insulin

    change in concentration of insulin (mUI/L)

    Time frame: 3-month

  6. Blood analysis- total cholesterol

    change in concentration of total cholesterol (mg/dl)

    Time frame: 3-month

  7. Blood analysis-LDL cholesterol

    change in concentration of LDL cholesterol (mg/dl)

    Time frame: 3-month

  8. Blood analysis-HDL cholesterol

    change in concentration HDL cholesterol (mg/dl)

    Time frame: 3-month

  9. Blood analysis-triglycerides (mg/dl)

    change in concentration of triglycerides (mg/dl)

    Time frame: 3-month

  10. Blood analysis- vitamins-B6

    change in concentration of B6(mcg/L)

    Time frame: 3-month

  11. Blood analysis- vitamins-B12

    change in concentration of B12 (ng/L)

    Time frame: 3-month

  12. Blood analysis- vitamins-folate

    change in concentration of folate (mcg/L)

    Time frame: 3-month

  13. Blood analysis- vitamins-Vitamin D

    change in concentration of Vitamin D (mcg/L)

    Time frame: 3-month

  14. Blood analysis- iron status

    change in concentration of iron (mcg/dl)

    Time frame: 3-month

  15. Blood analysis- ferritin status

    change in concentration of ferritin (mcg/L)

    Time frame: 3-month

  16. Blood analysis- Calcium

    change in concentration of calcium (mg/dl)

    Time frame: 3-month

  17. Blood analysis- total protein

    change in concentration of total protein (g/dl)

    Time frame: 3-month

  18. Anthropometric measurements - Body weight

    change in Body weight (kg)

    Time frame: 3-month

  19. Anthropometric measurements - circumferences

    change in waist and hip circumferences (cm)

    Time frame: 3-month

  20. Anthropometric measurements - Body composition

    change in fat mass and fat free mass (kg)

    Time frame: 3-month

  21. Physical activity

    change in metabolic equivalents of tasks (METs), measured by the short version of the International Physical Activity Questionnaire (IPAQ-sf)

    Time frame: 3-month

  22. Quality of life (VEGQOL)

    change in VEGQOL score ranging from 0-100 scale, with higer score indicating better QoL.

    Time frame: 3-month

  23. Adherence to the Mediterranean diet

    change in Mediterranean diet adherence score ranging from 0 to 9, with higer scores indicating better adherence

    Time frame: 3-month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jan 2028, 22 months after the start.

Of 393 non-industry interventional studies with no phase under Malnutrition, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 22 months is close to that.

Counting every sponsor, half of 419 studies reached it within 22 months; a quarter within 11 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2026
First posted
Jun 10, 2026
StartActual
Mar 26, 2026
Primary completionEst.
Jan 26, 2028
CompletionEst.
Jan 26, 2028
Last update
Jun 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07638839
Responsible party
Sponsor
First posted
Jun 10, 2026
Start date
Mar 26, 2026
Primary completion
Jan 26, 2028 (estimated)
Completion
Jan 26, 2028 (estimated)
Last update
Jun 10, 2026

Study contacts

Patrizia Gnagnarella, PhD
Contact
patrizia.gnagnarella@ieo.it
+39 0257489823
Patrizia Gnagnarella, PhD
principal investigator · European Institute of Oncology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion